Resmed paid its 5 named executives $30.5M in total in FY2026 (Jun). CEO Michael J. Farrell was paid $16.2M of that.
PayNo stock prices for these years
Pay of each named executive
Michael J. FarrellChief executive officer
| FY2026 (Jun) | ||||||
| FY2025 (Jun) | ||||||
| FY2024 (Jun) |
3 years
Justin LeongChief product officer
| FY2026 (Jun) | ||||||
| FY2025 (Jun) | ||||||
| FY2024 (Jun) |
3 years
Brett SandercockChief financial officer
| FY2026 (Jun) | ||||||
| FY2025 (Jun) | ||||||
| FY2024 (Jun) | ||||||
| FY2023 (Jun) | ||||||
| FY2022 (Jun) | ||||||
| FY2021 (Jun) |
6 years
Aaron BloomerChief financial officer
| FY2026 (Jun) |
1 year
Mike RiderGlobal general counsel and secretary
| FY2026 (Jun) | ||||||
| FY2025 (Jun) | ||||||
| FY2024 (Jun) |
3 years
CEO pay against the pay peers
In FY2026 (Jun), the median CEO pay of the 1 peer with pay on file was $11.5M. The CEO of Resmed was paid $16.2M, 41% above the median.
- 1ResmedThis company
- 2STERIS
- 3Agilent TechnologiesNot disclosed
- 4Align TechnologyNot disclosed
- 5Baxter InternationalNot disclosed
- 6Bio-Rad Laboratories, Inc.Not disclosed
- 7Boston ScientificNot disclosed
- 8Charles River Laboratories InternationalNot disclosed
- 9DexcomNot disclosed
- 10Edwards LifesciencesNot disclosed
- 11Hologic Inc.Not disclosed
- 12IDEXX Laboratories, Inc.Not disclosed
- 13Iqvia HoldingsNot disclosed
- 14IlluminaNot disclosed
- 15Intuitive SurgicalNot disclosed
- 16Mettler Toledo International Inc/Not disclosed
- 17Revvity, Inc. (formerly PerkinElmer)Not disclosed
- 18Teleflex IncorporatedNot disclosed
- 19Cooper CompaniesNot disclosed
- 20Waters CorporationNot disclosed
'%3e%3cg%20id='Clip-2'%3e%3c/g%3e%3cpolyline%20id='Fill-1'%20class='st0'%20points='0.1,56.1%200.2,148.5%2017.7,148.5%2017.7,56.1%200.1,56.1%20'/%3e%3cpolyline%20id='Fill-3'%20class='st1'%20points='46.9,0.9%2046.9,148.5%2064.6,148.5%2064.6,0.9%2046.9,0.9%20'/%3e%3cpolygon%20id='Fill-4'%20class='st1'%20points='94.7,148.5%20112.4,148.5%20112.4,0.9%2094.7,0.9%20'/%3e%3cpath%20id='Fill-5'%20class='st1'%20d='M219.3,148.5h-17.6v-14.2h-0.4c-10.9,23.8-64,25.9-64-18.7l-0.1-59.5h17.6v54.6%20c0,17.4,10,23.8,21.1,23.8c14.6,0,25.8-9.4,25.7-30.8V56.1h17.6L219.3,148.5'/%3e%3c/g%3e%3cpath%20id='Fill-7'%20class='st1'%20d='M244.9,56.1h16.4v14.4h0.4c1.8-5.5,13.1-16.8,29.7-16.8c13.7,0,23,5.9,28.9,17.2%20c6.1-11.3,18.2-17.2,29.3-17.2c28.5,0,35.1,20.3,35.2,41v53.9h-17.6V97.1c0-14.1-3-26.9-19.9-26.9c-17,0-23.6,11.5-23.6,27.9v50.5%20H306v-48.4c0-17.6-2.6-30-19.5-30c-12.7,0-24,9.6-24,30.4v48h-17.6V56.1'/%3e%3cpolygon%20id='Fill-8'%20class='st1'%20points='408.6,148.5%20426.2,148.5%20426.2,56.1%20408.6,56.1%20'/%3e%3cpath%20id='Fill-9'%20class='st1'%20d='M452.1,56.1h17.6v14.2h0.4c10.9-23.8,64-25.9,64,18.7v59.5h-17.6V93.9c0-17.4-10-23.8-21.1-23.8%20c-14.6,0-25.8,9.4-25.7,30.8v47.6h-17.6L452.1,56.1'/%3e%3cg%20id='Group-13'%20transform='translate(0.000000,%2012.000000)'%3e%3cg%20id='Clip-11'%3e%3c/g%3e%3cpath%20id='Fill-10'%20class='st1'%20d='M567.6,66.3c6.4-4.9,12.9-10.5,26.3-10.5c15,0,22.1,9.9,22.1,19.5v3.9c-17.6,0-63.8-2.5-63.8,32%20c0,18,14.8,27.7,32,27.7c14,0,24.6-4.5,32.4-16.4h0.4c0,4.7,0.2,9.4,0.6,14.1h15.6c-1.3-10.7-0.8-65-0.8-64%20c0-35.6-51.9-39.2-75.3-17.2L567.6,66.3z%20M616.1,92.1V98c0,12.5-6.8,26.9-26.3,26.9c-12.1,0-19.9-4.5-19.9-15%20C569.8,91.3,600.3,92.1,616.1,92.1L616.1,92.1z'/%3e%3cpath%20id='Fill-12'%20class='st0'%20d='M11.8,0C5.3,0,0,5.3,0,11.8s5.3,11.8,11.8,11.8s11.8-5.3,11.8-11.8S18.3,0,11.8,0'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.